key: cord-0884576-68g8noys authors: Ul Alam, A. S. M. Rubayet; Rafiul Islam, M.; Shaminur Rahman, M.; Islam, Ovinu Kibria; Anwar Hossain, M. title: Understanding the possible origin and genotyping of first Bangladeshi SARS‐CoV‐2 strain date: 2020-06-03 journal: J Med Virol DOI: 10.1002/jmv.26115 sha: 58d1d8be167859f2dc8904ba04e7ff2c3a318157 doc_id: 884576 cord_uid: 68g8noys The novel coronavirus, SARS‐CoV‐2, causes the unfathomable pandemic in the history of humankind. Bangladesh is also a victim of this critical situation. To investigate the genomic features of the pathogen, the first complete genome of the virus has very recently been published. Therefore, the long awaiting questions regarding the possible origin and typing of the strain(s) can now be answered. Here, we endeavor to mainly discuss the published reports or online‐accessed data (results) regarding those issues and presented a comprehensive picture of the typing of the virus alongside the probable origin of the sub‐clade containing Bangladeshi strain. Our observation suggested that this strain might have originated from the United Kingdom (UK) or other European countries epidemiologically linked to the UK. According to different genotyping classification schemes, this strain belongs to A2a clade under G major clade, is of B and/or L type, and is a SARS‐CoV‐2a sub‐strain. In the forwarding days, randomized genome data will certainly voluminate in Bangladesh, however because of globalization and immigrant movements, we urgently need a mass regional sequencing approach targeting the partial or complete genome that can link the epidemiological data and may help in further clinical interventions. This article is protected by copyright. All rights reserved. discuss the published reports or online-accessed data (results) regarding those issues and presented a comprehensive picture of the typing of the virus alongside the probable origin of the sub-clade containing Bangladeshi strain. Our observation suggested that this strain might have originated from the United Kingdom (UK) or other European countries epidemiologically linked to the UK. According to different genotyping classification schemes, this strain belongs to A2a clade under G major clade, is of B and/or L type, and is a SARS-CoV-2a sub-strain. In the forwarding days, randomized genome data will certainly voluminate in Bangladesh, however because of globalization and immigrant movements, we urgently need a mass regional sequencing approach targeting the partial or complete genome that can link the epidemiological data and may help in further clinical interventions. April. Also, other closely related isolates within the respective sub-clade are mostly from European countries (Figure 1 ). It should be noted that the nearest origin and tMRCA of the Bangladeshi strain can be changed since this is a dynamic evolving tree, which is continuously updated based on Glycine (synonymous to G clade according to GISAID phylogenetic tree) and another mutation at 323 rd position of NSP12 (Proline to Leucine) 1, 3 . In addition to this report, which is probably more aggressive and can spread quickly although human intervention had been decreasing relative frequency of the L type 6 . Interestingly, based on another classification scheme, this is a SARS-CoV-2a sub-strain due to the presence of a unique trinucleotide-bloc mutation present within the genome at the N protein coding region (28,881-28,883: AAC) 8 , and the translated G204R (Glycine to Arginine) mutation places the strain within the GR clade under the major G clade 1 . The resulting amino acid substitutions (lysine and arginine) might reduce the pathogenicity of the SARS-CoV-2. In perspective of the ORF3a, Bangladeshi isolate has the identical nucleotide (base 'G') at two mutually exclusive sites (25,563 and 26,144), compared to 'wild-type' 2g sub-strain (base 'T'), wherein G25563T and G26144T are linked with the emergence of GH and V (or synonymously type C 7 ) clades 1 , respectively. The resulting non-synonymous mutations of the 3a protein (Q57H: GlutamineHistidine and G251V: GlycineValine), albeit not within any of its six functional domains (I to VI) 11 , might have positive 12 or negative 8 impact on structural stability and binding affinity, possibly influencing disease pathogenesis (i.e. modulating the immunological reaction, notably 'cytokine storm' in the host 8 ) and drug resistance capacity 11 . It was also claimed in the report of Ayub (2020) as of 9 th April 2020 that, predominant presence of SARS-CoV-2a sub-strain in a particular city or country, such as United Kingdom (26%), Belgium (31%), Netherland (50%), Portugal (60%), can be a cause of reduced cases of COVID-19 8 . However, the Bangladeshi sequence also have two unique mutations in the ORF1ab region. Among them, a mutation (E261D, i.e. glutamic to aspartic acid) in the NSP13 protein, RNA helicase and/or 5′ triphosphatase, found only in one Austrian strain (hCoV-19/Austria/CeMM0004/2020) collected on 3 rd March 2020 1, 13 . Remarkably, another mutation (I120F; isoleucine to phenylalanine) in the NSP2 (predicted role in viral pathogenicity) 14 is not found in any other sequences available in the GISAID database 1 . Overall, both of the unique mutations may not be that much significant considering the similar chemical properties of the amino acids and will need further molecular investigation to find any clue. Overall, it is speculated that Bangladesh can be an important source of mixed virus strains. This may be explained by the fact of returning a lot of immigrant people to Bangladesh from other countries, some of which were declared as the epicenters for SARS-CoV-2 15 . In this context, extensive sequencing of representative districts or zones, therefore, will give a concrete and comprehensive basis to bring out significant information as expected in an ongoing outbreak. Moreover, the sequence data should also be correlated with the patient history. It is important to mark here that we may not need to go for complete/partial genome sequencing because scientists may soon find out the crucial, epidemiological marker proteins from the existing sequence information linked to clinical importance, which can also be useful to track the presence of types alongside crucial mutations. Targeted sequencing of only that protein or part of the protein will be sufficient for getting the relevant information and will give the breadth of opportunity for matching the clinical history and spreading pattern more easily by the scientists of the world. To conclude, a comprehensive, rational analyses considering the related virus strains or relevant countries rather than taking all the strains into the computational run will bring up a clearer picture, albeit more genomic data alongside the patient history from Bangladesh is a prerequisite here. Global initiative on sharing all influenza data -from vision to reality Nextstrain: real-time tracking of pathogen evolution The Business Standard Airline industry counting losses amid COVID-19 pandemic On the origin and continuing evolution of SARS-CoV-2 Phylogenetic network analysis of SARS-CoV-2 genomes Reporting Two SARS-CoV-2 Strains Based on A Unique Trinucleotide-Bloc Mutation and Their Potential Pathogenic Difference Distinct Viral Clades of SARS-CoV-2: Implications for Modeling of Viral Spread Global Spread of SARS-CoV-2 Subtype with Spike Protein Mutation D614G is Shaped by Human Genomic Variations that Regulate Expression of TMPRSS2 and MX1 Genes. bioRxiv SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis Genome-Wide Identification and Characterization of Point Mutations in the SARS Osong Public Health Res Perspect Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis Failure in initial stage containment of global COVID-19 epicenters